Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3
Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see how two classes of blood pressure
medications,angiotensin-converting enzyme inhibitors (Ace inhibitors) and angiotensin
receptor blockers (ARBs), differ in their long term effects on certain chemicals in the body
and on the carotid arteries.
Phase:
Phase 3
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) University of Washington